UNSPSC 51392601: Cafedrine

This classification denotes a cns stimulant with the molecular formula C18H23N5O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0UYY5V4U2Q, chemically known as 1h-purine-2,6-dione, 3,7-dihydro-7-(2-((2-hydroxy-1-methyl-2-phenylethyl)amino)ethyl)-1,3-dimethyl- (van) but generally known as cafedrine, which bears US NIH Compound Identifier 71740. European Medicines Agency schedules Cafedrine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06044MIG.

UNSPSC 51392601 Cafedrine is a Commodity code, but the recent state and local opportunity tagged under it does not reflect pharmaceutical compounds in the code's nominal scope. Seminole County, Florida issued IFB 60459723LAS in June 2026 seeking to procure 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually, with quarterly deliveries to the Seminole County Community Health Building in Sanford. The solicitation calls for a competitive bid with a two-year initial term plus one-year renewal option, fixed-fee pricing, and standard compliance requirements including drug-free workplace certification, E-Verify authorization, and potential FEMA-driven federal environmental regulations. However, Naloxone is an opioid antagonist and drug deactivation systems fall outside the cafedrine pharmaceutical category; the code appears to have been misapplied to this opportunity, suggesting either a tagging error or a significant scope mismatch between the UNSPSC designation and the actual procurement activity.

The source contains only one recent opportunity and provides no additional geographic spread or issuing-body pattern to characterize state and local procurement activity under this code. Without further opportunities demonstrating authentic cafedrine demand across jurisdictions, no reliable signal emerges regarding market concentration, regional activity, or repeat buyers in this commodity class.